# Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes

> **NCT03933306** · PHASE4 · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 496 (actual)

## Conditions studied

- Blood Pressure
- Dexmedetomidine
- High-risk Patients
- Abdominal Surgery
- Postoperative Complications

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo
- **OTHER:** Goal-directed blood pressure management
- **OTHER:** Routine blood pressure management

## Key facts

- **NCT ID:** NCT03933306
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-20
- **Primary completion:** 2020-10-29
- **Final completion:** 2024-05-30
- **Target enrollment:** 496 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933306, "Intraoperative Goal-directed Blood Pressure and Dexmedetomidine on Outcomes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03933306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*